Clemsza Tablet
Product Images NDC 71085-081

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Clemsza (NDC 71085-081). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ipg Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Clemastine 1)

FDA Label Image

Image Description (Image 081)

Image Description (Image 081)
This is a description for Clemastine Fumarate Tablets, USP. The usual adult dosage is one tablet one to three times daily. Each tablet contains 2.68 mg of clemastine fumarate. It is advised to store the medication at 20° to 25°C (68° to 77°F) in a light-resistant and USP-resistant closure. The medication is manufactured for IPG Pharmaceuticals, Inc. in Phoenix, AZ 85040. For full prescribing information, refer to the package insert. Keep this and all medications out of reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.